Ischemia modified albumin (IMA) and Protein Carbonyl (PC) have known as proteins that
are modified on the similar basis of oxidative stress induced protein modification and may …

Myocardial ischemia produces free radicals that catalyze a series of oxidative reactions that
damage healthy tissues. The N-terminal sequence of albumin is one of the proteins modified …

Objective To evaluate the diagnostic efficacy of ischemia modified albumin (IMA) and its
correlation with lipid profile, oxidative stress in acute myocardial infarct (AMI) patients …

Early identification of patients with acute myocardial infarction is of prime importance due to
the associated very high mortality. Only 22% of the patients presenting at emergency …

ABSTRACT Aims and Objectives: To find out if ischemia modified albumin can be a novel
marker in ischemic heart disease. Materials and methods: Retrospective chart-review of …

Introduction: Literature reports addressing ischemia modified albumin (IMA) as a good
marker for the early diagnosis of myocardial ischemia through albumin cobalt binding (ACB) …

Difficulty in establishing a diagnosis of acute coronary syndrome (ACS) in the clinical setting
has led researchers to investigate novel markers that show increased blood levels before …

BACKGROUND: Ischemia modified albumin (IMA), is a new biomarker of oxidative
processes involved with coronary artery disease (CAD). We determined serum IMA, high …

Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

BACKGROUND: Ischemia-modified albumin (IMA) has been shown to be a rapidly rising
and sensitive biochemical marker for the diagnosis of myocardial ischemia. In this study, we …